Why is Saroja Pharma In falling/rising?

As of 17-Sep, Saroja Pharma Industries India Ltd's stock price is flat at 47.05, with no change in percentage terms (0.00%). The stock has experienced a decline of 4.47% over the past week, while it has risen by 20.64% over the past month. Despite this recent monthly gain, the year-to-date performance shows a significant drop of 21.58%, and the one-year return is down by 22.87%. Today's price summary indicates that the stock is performing in line with its sector, but it is currently above the 50-day, 100-day, and 200-day moving averages, while below the 5-day and 20-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 50% compared to the 5-day average, which may indicate waning interest among investors.
In the broader market context, the Sensex has increased by 1.43% over the past week and 2.84% over the past month, contrasting with Saroja Pharma's recent performance. The stock's year-to-date decline of 21.58% is significantly worse than the Sensex's gain of 7.13% during the same period. This disparity suggests that while the stock has seen some recovery in the short term, it remains underperforming relative to the broader market, which could be contributing to the flat price movement observed today. The lack of positive or negative dashboard data further complicates the analysis of specific factors influencing the stock's recent performance.